This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Lincare Holdings Inc. (LNCR): Today's Featured Health Services Winner

Lincare Holdings (LNCR) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.3%. By the end of trading, Lincare Holdings rose 15 cents (0.7%) to $22.93 on heavy volume. Throughout the day, 1.4 million shares of Lincare Holdings exchanged hands as compared to its average daily volume of 718,300 shares. The stock ranged in a price between $22.63-$23.14 after having opened the day at $22.78 as compared to the previous trading day's close of $22.78. Other companies within the Health Services industry that increased today were: Theragenics Corporation (TGX), up 15%, ImmunoCellular Therapeutics (IMUC), up 13.1%, Iridex Corporation (IRIX), up 12.1%, and Utah Medical Products (UTMD), up 10.7%.

Lincare Holdings Inc. provides oxygen, respiratory, and other chronic therapy services to patients in the home. Lincare Holdings has a market cap of $2 billion and is part of the health care sector. The company has a P/E ratio of 11.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 11.4% year to date as of the close of trading on Wednesday. Currently there are three analysts that rate Lincare Holdings a buy, no analysts rate it a sell, and four rate it a hold.

TheStreet Ratings rates Lincare Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, notable return on equity, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Sunshine Heart (SSH), down 16.5%, Dehaier Medical Systems (DHRM), down 16.4%, D Medical Industries (DMED), down 14.6%, and Dynacq Healthcare (DYII), down 14.3%, were all losers within the health services industry with UnitedHealth Group (UNH) being today's health services industry loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR (XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care (RXD).

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,500.69 -0.96 -0.01%
S&P 500 1,877.28 +1.89 0.10%
NASDAQ 4,142.9270 +15.96 0.39%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs